News About: Pharm. Industry
9 companies including Yuhan, Green Cross and Hanmi Pharm, first to adopt ‘ISO 37001’
In order to keep the pharmaceutical distribution order transparent, the Korean pharmaceutical industry has accelerated in the self-purification process and reforming its own system.
A process has been scheduled to ad...
Pharma industry accelerate rebate eradication process well-prepared plans
The pharmaceutical companies’ process to establish ethical management will be accelerated by eradicating illegal rebates.
The Korea Pharmaceutical and Bio-Pharma Manufacturers Association held a Chairmen’s meeting on...
‘Green Light’ on Daewoong Pharmaceutical with Nabota’s USAN registration
Daewoong Pharmaceutical(CEO Jong-Wook Lee) announced a U.S. medical substance name for ‘Nabota,’ a botulinum toxin, was registered as ‘prabotulinumtoxin A.’
The USAN(United States Adopted Names) is one of the interna...
LG Household & Health Care acquires Tai Guk Pharm for KRW 44.6 billion
LG Household & Health Care(CEO Seok-Yong Cha) signed an agreement to acquire 80% shares of Tai Guk Pharm, a dermatological treatment company that is famous for Domina Cream, a freckle treatment, for KRW 44.6 billion.
...
Pharmaceutical companies’ dilemma over relationship with CSOs
While CSOs(contract sales organizations) have frequently been mentioned in the pharmaceutical field, pharmaceutical companies have concerns over CSOs.
In the past, pharmaceutical companies used to have a superior sta...
AZ, “We do not consider withdrawing Tagrisso from getting health insurance benefits”
While patient associations are pressing the National Health Insurance Service(NHIS) and AstraZeneca to conclude the drug price negotiation for the company’s non-small cell lung cancer treatment, Tagrisso(generic name:...
GSK strengthens R&D partnerships for novel drugs with Korean research centers
GSK Korea(CEO/President Yoo-Seok Hong) held a MOU ceremony with Yonsei University College of Medicine Songdang Cancer Center(Director Hyun-Cheol Jung) on the 2nd and announced they will strengthen a mutual cooperation...
Kyung Name Pharm’s ‘Lemona’ climbed up the Great Wall of China
Kyung Nam Pharm announced on the 1st that the company’s Lemona and Lemona C Tab acquired the final approval of registration from the China Food and Drug Administration getting over the THAAD issue.
The CFDA’s food an...
‘Custom vs. Compensation,’ issue over Novartis’ rebate trial
The Novartis’ rebate trial has been repeated without any solution to a question if symposiums and publication are just an industrial custom or part of compensation.
In the meantime, a newly-added witness has caused c...
Samsung Biologics & Merck’s strategic agreement of manufacturing biologics
A pharmaceutical and chemical company Merck announced on the 2nd the company signed a memorandum of understanding(MOU) to agree on strategically manufacture biologics and develop their manufacturing process with Samsu...
